The aim of the present study is to evaluate the effects of Lactobacillus coryniformis K8 consumption on the incidence and severity of Covid-19 in health workers exposed to the virus. This is a preventive study
Dietary Supplement: Probiotic
The probiotic group will received one capsule with Lactobacillus K8 per day (3x10^9 cfu/day) during 2 months
Dietary Supplement: Control
The control group will received one placebo capsule per day during 2 months
Inclusion Criteria:
1. Persons over 20 years of age.
2. Active healthcare personnel, who attend patients with COVID-19 disease, including all
professional categories, medicine, nursing and warders.
3. Ability to complete surveys.
4. Signature of informed consent
Exclusion Criteria:
1. Person with positive test of COVID-19 confirmed by PCR test or serology
2. Person with concomitant pathology HIV, transplant, active oncology or other type of
active immunosuppression
3. Pregnant women or women with intention to become pregnant in the next 2 months.
Raquel Rodriguez Blanque
Granada, Spain
Investigator: Raquel Rodriguez Blanque
Contact: +34 958 023 000
raquel.rodriguez.blanque.sspa@juntadeandalucia.es
Raquel Rodriguez Blanque
+34 958 023 000
raquel.rodriguez.blanque.sspa@juntadeandalucia.es